Gene Pharming Europe B.V.
Records under this name other than patents Gene Pharming Europe B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Gene Pharming Europe B.V.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,713,662 | Production of collagen in the milk of transgenic mammals Formerly held Term ended Term ended Jun 27, 2022 · USPTO record | Term ended | Term ended Jun 27, 2022 | USPTO record |
| US 6,140,552 | Production of recombinant polypeptides by bovine species and transgenic methods Formerly held Term ended Term ended Oct 31, 2017 · USPTO record | Term ended | Term ended Oct 31, 2017 | USPTO record |
| US 6,013,857 | Transgenic bovines and milk from transgenic bovines Formerly held Term ended Term ended Jan 11, 2017 · USPTO record | Term ended | Term ended Jan 11, 2017 | USPTO record |
| US 6,066,725 | Production of recombinant polypeptides by bovine species and transgenic methods Formerly held Lapsed on the fee record Ended May 23, 2012 · USPTO record | Lapsed on the fee record | Ended May 23, 2012 | USPTO record |
| US 4,873,316 | Isolation of exogenous recombinant proteins from the milk of transgenic mammals Formerly held Term ended Term ended no later than Oct 10, 2009 · Low confidence | Term ended | Term ended no later than Oct 10, 2009 | Low confidence |
| US 5,304,489 | DNA sequences to target proteins to the mammary gland for efficient secretion Formerly held Term ended Term ended no later than Apr 19, 2014 · Low confidence | Term ended | Term ended no later than Apr 19, 2014 | Low confidence |
| US 5,565,362 | DNA sequences to target proteins to the mammary gland for efficient secretion Formerly held Term ended Term ended no later than Oct 15, 2016 · Low confidence | Term ended | Term ended no later than Oct 15, 2016 | Low confidence |
| US 5,612,205 | Homologous recombination in mammalian cells Formerly held Term ended Term ended no later than Mar 18, 2017 · Low confidence | Term ended | Term ended no later than Mar 18, 2017 | Low confidence |
| US 5,633,076 | Method of producing a transgenic bovine or transgenic bovine embryo Formerly held Term ended Term ended no later than May 27, 2017 · Low confidence | Term ended | Term ended no later than May 27, 2017 | Low confidence |
| US 5,721,367 | Homologous recombination in mammalian cells Formerly held Term ended Term ended no later than Feb 24, 2018 · Low confidence | Term ended | Term ended no later than Feb 24, 2018 | Low confidence |